Cancer Screening

  • Mita Sanghavi GoelEmail author
  • Jenny J. Lin


Screening is a process of testing asymptomatic individuals. In 1968, the World Health Organization proposed a set of criteria to evaluate various screening tests, commonly known as “Wilson’s criteria.” In 2008, with acknowledgement of emerging criteria, the criteria were updated. In this chapter, we consider a variety of screening strategies for the early detection of cancer. There are specific concepts related to screening that will be discussed.


Screening Mammogram Papanicolaou Human papilloma virus Colonoscopy Fecal immunohistochemical test Stool DNA Prostate-specific antigen 


  1. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. New Engl J Med. 2009;360(13):1310–9.CrossRefGoogle Scholar
  2. Ashton-Prolla P, Giacomazzi J, Schmidt AV, Roth FL, Palmero EI, Kalakun L, et al. Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care. BMC Cancer. 2009;9:283.CrossRefGoogle Scholar
  3. Canadian Task Force on Preventive Health Care. Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) Working Group. 2011.
  4. Clinical practice guidelines we can trust. Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, Editors. Washington, DC: The National Academies Press. 2011.Google Scholar
  5. Elwyn G, Coulter A, Laitner S, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. BMJ. 2010;341:c5146.CrossRefGoogle Scholar
  6. Evans DG, Eccles DM, Rahman N, Young K, Bulman M, Amir E, et al. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet. 2004;41(6):474–80.CrossRefGoogle Scholar
  7. Gilpin CA, Carson N, Hunter AG. A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. Clin Genet. 2000;58(4):299–308.CrossRefGoogle Scholar
  8. Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer. 2006;107(8):1769–76.CrossRefGoogle Scholar
  9. Jin J. Breast cancer screening: benefits and harms. JAMA. 2014;312(23):2585.CrossRefGoogle Scholar
  10. Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314(15):1615–34.CrossRefGoogle Scholar
  11. National Cancer Institute Surveillance Epidemiology, and End Results Program. Cancer stat facts: female breast cancer.
  12. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327–35.CrossRefGoogle Scholar
  13. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. World Health Organization. 2011.Google Scholar
  14. Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112(7):1016–30.CrossRefGoogle Scholar
  15. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. New Engl J Med. 2009;360(13):1320–8.CrossRefGoogle Scholar
  16. Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2017;67(2):100–21.CrossRefGoogle Scholar
  17. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111–30.CrossRefGoogle Scholar
  18. U.S. Preventive Service Task Force. Clinical Summary Breast Cancer: Screening. 2016.
  19. Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, et al. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. 2015;107(5).Google Scholar
  20. Wolf AM, Fontham ET, Church TR, Flowers CR, Guerra CE, LaMonte SJ, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250–81.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of General Internal Medicine and GeriatricsFeinberg School of Medicine, Northwestern UniversityChicagoUSA
  2. 2.Division of General Internal MedicineIcahn School of Medicine at Mount SinaiNew YorkUSA

Personalised recommendations